Résumé
Morinda morindoides est une plante qui est citée de façon récurrente dans plusieurs prescriptions thérapeutiques. Afin de mieux connaître cette plante et de pouvoir l’identifier sur le terrain, nous avons, dans cette étude, fait sa description botanique suivie d’une exploration de son activité antifongique. Il ressort de cette étude que Morinda morindoides (Rubiaceae) est une espèce guinéo-congolaise qui se retrouve dans les lisières des forêts. C’est une liane grimpante avec des feuilles opposées et possédant des fruits bosselés. Cette plante possède une activité antifongique in vitro sur Cryptococcus neoformans. Parmi les extraits testés, la fraction 1 (F1) (CMF = 0,78 mg/ml; CI50 = 0,08 ± 0,02 mg/ml) est la plus active.
Abstract
Morinda morindoides is a plant that is mentioned in a recurrent way in several therapeutic prescriptions. In order to know this plant and be able to identify it on the land, we have, in this study, made its botanical description followed of an exploration of its antifungal activity. It is evident from this study that Morinda morindoides (Rubiaceae) is a guineo-congolese species that meets in the borders of the forests. It is a trailing liana with opposite leaves and propertied of the bumpy fruits that yellow to maturity. This plant possesses an in vitro antifungal activity on Cryptococ-cus neoformans. Among the tested extracts, the fraction 1 (F1) [MFC = 0.78 mg/ml; IC50 = 0.08 ± 0.02 mg/ml] is the most active.
Références
Ajello L, Georg LK, Kaplan W, Kaufman L (1963) Laboratory manual for medical mycology (2nd Edition). John Wiley and sons, New York, USA, 158 p
Bahi C, Djaman AJ, Nguessan JD, et al. (2003) Effet de la fraction chromatographique d’un extrait aqueux de Morinda morindoides (Bak.) Milne-Redl (Rubiaceae) et Mareya micranta (Benth.) Müll. Arg (Euphorbiaceae) sur l’activité de l’acétylcholinestérase de lapin. J Sci Pharm Biol 1: 36–43
Bahi C, Nguessan JD, Guédé Guina F (2000) Mise en évidence d’une action myorelaxante et cholinolytique de BGG, un antidiarrhéique de source naturelle. Afr Biomed 1: 11–18
Cimanga RK, Kambou K, Tona L, et al. (2006) Cytotoxicity and in vitro susceptibility of Entamoeba histolytica to Morinda morindoides leaf extracts and its isolated constituents. J Ethnopharmacol 107: 83–90
Cimanga K, Kambu K, Tona L, et al. (2006) Antiamoebic activity of iridoids from Morinda morindoides leaves. Planta Medica 72: 751–753
Cimanga K, Hermans N, Apers S, et al. (2003) Complement-inhibiting iridoids from Morinda morindoides. J Nat Prod 66: 97–102
Cimanga K, De Bruyne T, Hu JP, et al. (1999) Constituents from Morinda morindoides leaves as inhibitors of xanthine oxidase and scavengers of superoxide anions. Pharm Pharmacol Commun 5: 419–424
Cimanga K (1997) Te biologically active constituents from two African medicinal plants. Cryptolepis sanguinolenta (Lindl.) Schlechter (Periplo-caeae) and Morinda morindoides (Baker) Milne-Redhead (Rubiaceae). PhD Tesis, Unversity of Antwerp (UIA), Antwerp, Belgium, 210 p
Cimanga K, De Bruyne T, Van Poel B, et al. (1997) Complement-modulating properties of a kaempferol 7-O-rhamnosyl-sophoroside from the leaves of Morinda morindoides. Planta Medica 63: 220–223
Cimanga K, De Bruyne T, Lasure A, et al. (1995) Flavonoid O-glycosides from the leaves of Morinda morindoides. Phytochemistry 38: 1301–1303
Cimanga K, De Bruyne T, Lasure A, et al. (1995) In vitro anticom-plementary activity of constituents from Morinda morindoides. J Nat Prod 58: 372–378
Dromer F, Dupont B (1996) The increasing problem of fungal infections in the immunocompromised host. J Mycol Med 6: 1–6
Dupont BF, Dromer F, Improvisi L (1996) The problem of azole resistance in Candida. Commentary. J Mycol et de Med 6: 12–19
Garrigues JC, Perez E, Linas MD, et al. (1996) Tests in vitro et études quantitatives de relation structures-activité (QSAR) pour la détermination des propriétés antiaspergillaires d’une série d’analogues de glycolipides. J Mycol Med 6: 111–117
Guédé Guina F, Vangah-Manda M, Harouna D, Bahi C (1993) Potencies of misca, a plant source concentrate against fungi. J Ethnophar-macol 14: 45–53
Guédé Guina F, Wangah-Manda M, Bonga GM, De Souza C (1995) Activité antimicrobienne d’un extrait végétal contre les germes opportunistes au cours du sida. Rev Med Pharmacol Afr 1: 13–19
Holt RJ (1975) Laboratory test of antifungal drugs. J Clin Pathol 2: 767–774
Kambou K (1990) Éléments de phytothérapie comparée. Plantes médicinales africaines, CRP-Kinshasa, pp 61–74
Meite S, Nguessan JD, Bahi C, et al. (2009) Antidiarrheal activity of the ethyl acetate extract of Morinda morindoides in rats. Trop J Pharm Res 8(3): 201–207
Nguessan JD, Trébissou JND, Bahi C, et al. (2004) Effets de BGG, F5 (fraction chromatographique de Morinda morindoides) sur la pression artérielle carotidienne de lapin. Rev Med Pharmacol Afr 18: 1–10
Nguessan JD, Trébissou JND, Bahi C, et al. (2002) Effets de BGG, F5 (fraction chromatographique de Morinda morindoides) sur l’activité contractile du cœur isolé de rat. Rev Iv Sci Tech 3: 127–139
Séri SC (2006) Contribution à l’étude chimique et structurale des feuilles de Morinda morindoides (Rubiaceae). Mémoire de DEA, sciences physiques des stuctures. Option chimie organique, université de Cocody, UFR SSMT, Abidjan, Côte-d’Ivoire, 48 p
Stevens DA (1996) Oral amphotericin B as an antifungal agent. J Mycol Med 6(Suppl II): 1–2
Tona L, Cimanga RK, Mesia K, et al. (2004) In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J Ethnopharmacol 1: 27–32
Tona L, Mesia K, Ngimbi N P, et al. (2001) In vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllan-thus niruri. Ann Trop Med Parasitol 1: 47–49
Tona L, Ngimbi N P, Tsakala M, et al. (1999) Antimalarial activity of 20 crude extracts from nine African medicinal plants used in Kinshasa, Congo. J Ethnopharmacol 68: 193–203
Tona L, Kambou K, Ngimbi N P, et al. (1998) Antimoebic and phyto-chemical screening of some Congolese medicinal plants. J Ethno-pharmacol 1: 57–65
Zirihi GN, Kra AKM, Etien DT (2007) Étude botanique et évaluation des activités antifongiques de Mitracarpus villosus (MV) (Rubiaceae) et Spermacoce verticillata (SV) (Rubiaceae) sur la croissance in vitro de Aspergillus fumigatus. Rev Med Pharmacol Afr 20: 9–18
Zirihi GN, Kra AKM (2003) Évaluation de l’activité antifongique de Microglossa pyrifolia (Larmarck) O. Kuntze (Asteraceae) “PYMI” sur la croissance in vitro de Candida albicans. Rev Med Pharmacol Afr 17: 11–18
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bagre, I., Bahi, C., Ouattara, K. et al. Étude botanique et exploration de l’activité antifongique de Morinda morindoides (Baker) Milne-Redh. sur la croissance in vitro de Cryptococcus neoformans . Phytothérapie 9, 136–141 (2011). https://doi.org/10.1007/s10298-011-0612-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10298-011-0612-y